No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia.

No Mutation Left Behind: The Impact of Reporting Recurrent Genetic Abnormalities on Outcomes of Patients with Acute Myeloid Leukemia. Acta Haematol. 2018 Feb 14;139(2):128-130 Authors: Brunner AM PMID: 29444505 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29444505?dopt=Abstract

Source: Acta Haematologica - February 14, 2018 Category: Hematology Authors: Brunner AM Tags: Acta Haematol Source Type: research

More News: Acute Leukemia | Acute Myeloid Leukemia | Genetics | Hematology | Leukemia